Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	NET1 MYCBP2 OBSCN ARHGEF17 ARHGEF16 ARHGAP29 HERC2 TBC1D3I TBC1D3G RGL2 TNS3 TBC1D3K TBC1D3F IPO5 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 NGB TBC1D3C TBC1D3B KIAA1755 RINL	5.61e-10	507	223	25	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	NET1 MYCBP2 OBSCN ARHGEF17 ARHGEF16 ARHGAP29 HERC2 TBC1D3I TBC1D3G RGL2 TNS3 TBC1D3K TBC1D3F IPO5 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 NGB TBC1D3C TBC1D3B KIAA1755 RINL	5.61e-10	507	223	25	GO:0030695
GeneOntologyMolecularFunction	enzyme regulator activity	CDKN2A CDKN2D NET1 MYCBP2 NAIP OBSCN ARHGEF17 ARHGEF16 BRPF1 ARHGAP29 PPP1R37 HERC2 TBC1D3I TBC1D3G RGL2 PIF1 TNS3 TBC1D3K TBC1D3F IPO5 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 NGB PARP8 TBC1D3C TBC1D3B CCNF GTF2F1 KIAA1755 RINL PIK3R5	7.78e-06	1418	223	35	GO:0030234
GeneOntologyMolecularFunction	ribose phosphate diphosphokinase activity	PRPS2 PRPS1L1 PRPS1	1.35e-05	5	223	3	GO:0004749
GeneOntologyMolecularFunction	GTPase activator activity	ARHGAP29 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B RINL	1.63e-05	279	223	13	GO:0005096
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity	SYNJ1 SYNJ2 PIKFYVE	2.68e-05	6	223	3	GO:0043813
GeneOntologyMolecularFunction	diphosphotransferase activity	PRPS2 PRPS1L1 PRPS1	2.68e-05	6	223	3	GO:0016778
GeneOntologyMolecularFunction	mRNA N6-methyladenosine dioxygenase activity	ALKBH5 FTO	1.24e-04	2	223	2	GO:1990931
GeneOntologyMolecularFunction	glutamate receptor activity	GRID2 GRIN2C GRIN2D GRM2	2.17e-04	27	223	4	GO:0008066
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	NET1 MYCBP2 OBSCN ARHGEF17 ARHGEF16 HERC2 RGL2 PLEKHG4 KIAA1755 RINL	2.83e-04	231	223	10	GO:0005085
GeneOntologyMolecularFunction	phosphatidylinositol phosphate 5-phosphatase activity	SYNJ1 SYNJ2 PIKFYVE	3.62e-04	13	223	3	GO:0034595
GeneOntologyMolecularFunction	phenanthrene-9,10-epoxide hydrolase activity	AKR7L AKR7A3	3.70e-04	3	223	2	GO:0019119
GeneOntologyMolecularFunction	phenanthrene-epoxide hydrolase activity	AKR7L AKR7A3	3.70e-04	3	223	2	GO:0019118
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	SYNJ1 SYNJ2 PIKFYVE	6.91e-04	16	223	3	GO:0106018
GeneOntologyBiologicalProcess	activation of GTPase activity	ARHGEF16 ARHGAP29 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 TBC1D3C TBC1D3B CRK	8.88e-13	109	224	15	GO:0090630
GeneOntologyBiologicalProcess	regulation of GTPase activity	NET1 RTN4R ARHGEF16 ARHGAP29 RIPOR1 TBC1D3I TBC1D3G PLXNA1 TNS3 TBC1D3K TBC1D3F PLXNA3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 TBC1D3C TBC1D3B CRK	1.21e-10	335	224	21	GO:0043087
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	NET1 RTN4R ARHGEF16 ARHGAP29 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 TBC1D3C TBC1D3B CRK	1.54e-09	244	224	17	GO:0043547
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	CDKN2A NET1 RTN4R BCL2 ARHGEF16 FCRL3 ARHGAP29 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 TBC1D3C TBC1D3B CRK	5.87e-07	499	224	20	GO:0051345
GeneOntologyBiologicalProcess	regulation of hydrolase activity	CDKN2A CDKN2D NET1 RTN4R NAIP BCL2 ARHGEF16 FCRL3 ARHGAP29 RIPOR1 TBC1D3I TBC1D3G PLXNA1 TNS3 TBC1D3K TBC1D3F PLXNA3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PLEKHG4 TBC1D3C TBC1D3B CRK	3.63e-06	878	224	26	GO:0051336
GeneOntologyBiologicalProcess	nucleoside monophosphate biosynthetic process	PRPS2 PRPS1L1 ADSL DHODH DUT PRPS1	1.45e-05	49	224	6	GO:0009124
GeneOntologyBiologicalProcess	5-phosphoribose 1-diphosphate metabolic process	PRPS2 PRPS1L1 PRPS1	2.47e-05	6	224	3	GO:0046391
GeneOntologyBiologicalProcess	5-phosphoribose 1-diphosphate biosynthetic process	PRPS2 PRPS1L1 PRPS1	2.47e-05	6	224	3	GO:0006015
GeneOntologyBiologicalProcess	ribonucleoside monophosphate biosynthetic process	PRPS2 PRPS1L1 ADSL DHODH PRPS1	5.41e-05	38	224	5	GO:0009156
GeneOntologyBiologicalProcess	olfactory nerve formation	PLXNA1 PLXNA3	1.17e-04	2	224	2	GO:0021628
GeneOntologyCellularComponent	ribose phosphate diphosphokinase complex	PRPS2 PRPS1L1 PRPS1	1.21e-05	5	225	3	GO:0002189
Domain	TBC	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	2.75e-10	49	224	10	SM00164
Domain	RabGAP-TBC	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	6.26e-10	53	224	10	PF00566
Domain	Rab-GTPase-TBC_dom	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	9.19e-10	55	224	10	IPR000195
Domain	TBC_RABGAP	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	9.19e-10	55	224	10	PS50086
Domain	PRPP_SYNTHASE	PRPS2 PRPS1L1 PRPS1	1.70e-06	3	224	3	PS00114
Domain	PRib_PP_synth_CS	PRPS2 PRPS1L1 PRPS1	1.70e-06	3	224	3	IPR000842
Domain	Pribosyltran_N	PRPS2 PRPS1L1 PRPS1	1.67e-05	5	224	3	PF13793
Domain	Pribosyl_synth	PRPS2 PRPS1L1 PRPS1	1.67e-05	5	224	3	PF14572
Domain	Rib-P_diPkinase	PRPS2 PRPS1L1 PRPS1	1.67e-05	5	224	3	IPR005946
Domain	Pribosyltran_N	PRPS2 PRPS1L1 PRPS1	1.67e-05	5	224	3	IPR029099
Domain	Ig-like_fold	MYCBP2 OBSCN LINGO3 FCRL3 PTPRB HMCN2 NFATC2 PXDNL MYPN VSIG10L SPACA6 UNC5D PLXNA1 PLXNA3 SDK2 VWA1 PTPRU NFAM1 EBI3 LRRN4 IGSF21 ANKFN1	4.34e-05	706	224	22	IPR013783
Domain	DUF1866	SYNJ1 SYNJ2	1.43e-04	2	224	2	IPR015047
Domain	DUF1866	SYNJ1 SYNJ2	1.43e-04	2	224	2	PF08952
Domain	DUF1866	SYNJ1 SYNJ2	1.43e-04	2	224	2	SM01165
Domain	-	MYCBP2 OBSCN LINGO3 FCRL3 PTPRB NFATC2 PXDNL MYPN VSIG10L SPACA6 UNC5D PLXNA1 PLXNA3 SDK2 VWA1 PTPRU EBI3 LRRN4 IGSF21 ANKFN1	1.51e-04	663	224	20	2.60.40.10
Domain	ARM-type_fold	URB1 RRP12 ANKAR PKP2 RIPOR1 UNC79 IPO5 RNPEPL1 USP24 WDFY4 EIF4G1 PRKDC LRBA	2.40e-04	339	224	13	IPR016024
Domain	Pribosyltran	PRPS2 PRPS1L1 PRPS1	2.62e-04	11	224	3	PF00156
Domain	PRTase-like	PRPS2 PRPS1L1 PRPS1	3.46e-04	12	224	3	IPR029057
Domain	PRibTrfase_dom	PRPS2 PRPS1L1 PRPS1	3.46e-04	12	224	3	IPR000836
Domain	-	PRPS2 PRPS1L1 PRPS1	3.46e-04	12	224	3	3.40.50.2020
Domain	CAC1F_C	CACNA1D CACNA1F	4.26e-04	3	224	2	IPR031688
Domain	UCP038083_PDZ	GIPC2 GIPC3	4.26e-04	3	224	2	IPR017379
Domain	CAC1F_C	CACNA1D CACNA1F	4.26e-04	3	224	2	PF16885
Domain	EGF_CA	SVEP1 STAB1 HMCN2 VWA2 NOTCH4 FAT4 MEGF8	6.78e-04	122	224	7	SM00179
Domain	EGF-like_Ca-bd_dom	SVEP1 STAB1 HMCN2 VWA2 NOTCH4 FAT4 MEGF8	7.47e-04	124	224	7	IPR001881
Domain	fn3	OBSCN PTPRB SDK2 VWA1 PTPRU EBI3 LRRN4 ANKFN1	7.68e-04	162	224	8	PF00041
Domain	VDCC_L_a1su	CACNA1D CACNA1F	8.46e-04	4	224	2	IPR005446
Domain	DH_1	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	9.48e-04	63	224	5	PS00741
Domain	ANF_lig-bd_rcpt	GRID2 GRIN2C GRIN2D GRM2	9.75e-04	37	224	4	IPR001828
Domain	ANF_receptor	GRID2 GRIN2C GRIN2D GRM2	9.75e-04	37	224	4	PF01094
Domain	Peripla_BP_I	GRID2 GRIN2C GRIN2D GRM2	1.19e-03	39	224	4	IPR028082
Domain	GDS_CDC24_CS	NET1 OBSCN ARHGEF16 PLEKHG4	1.19e-03	39	224	4	IPR001331
Domain	Lig_chan-Glu_bd	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	PF10613
Domain	Glu/Gly-bd	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	IPR019594
Domain	Lig_chan-Glu_bd	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	SM00918
Domain	Iontro_rcpt	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	IPR001320
Domain	Iono_rcpt_met	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	IPR001508
Domain	Lig_chan	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	PF00060
Domain	PBPe	GRID2 GRIN2C GRIN2D	1.22e-03	18	224	3	SM00079
Domain	RhoGEF	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	1.34e-03	68	224	5	SM00325
Domain	NUT	NUTM2A NUTM2B	1.40e-03	5	224	2	IPR024310
Domain	NUT_N	NUTM2A NUTM2B	1.40e-03	5	224	2	IPR024309
Domain	PHR	MYCBP2 BTBD2	1.40e-03	5	224	2	IPR012983
Domain	NUT	NUTM2A NUTM2B	1.40e-03	5	224	2	PF12881
Domain	Syja_N	SYNJ1 SYNJ2	1.40e-03	5	224	2	PF02383
Domain	PHR	MYCBP2 BTBD2	1.40e-03	5	224	2	PF08005
Domain	SAC	SYNJ1 SYNJ2	1.40e-03	5	224	2	PS50275
Domain	SAC_dom	SYNJ1 SYNJ2	1.40e-03	5	224	2	IPR002013
Domain	RhoGEF	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	1.52e-03	70	224	5	PF00621
Domain	DH_2	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	1.52e-03	70	224	5	PS50010
Domain	-	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	1.62e-03	71	224	5	1.20.900.10
Domain	DH-domain	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	1.62e-03	71	224	5	IPR000219
Domain	FN3	OBSCN PTPRB SDK2 VWA1 PTPRU EBI3 LRRN4 ANKFN1	1.80e-03	185	224	8	SM00060
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	GPR179 TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B	3.26e-07	99	171	10	M46448
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	8.73e-25	11	231	11	16863688
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	GPR179 KSR1 TBC1D3G TBC1D3F TBC1D3E SDK2 TBC1D3 TBC1D3H TBC1D3D BTBD17 TBC1D3B	2.53e-12	74	231	11	16625196
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LZTR1 MAN2A2 MYCBP2 OBSCN ABCA7 ST14 RYR1 URB1 SYNJ1 RRP12 NAV1 RIPOR1 HERC2 RGL2 PLXNA1 PLXNA3 ITPRIPL2 RNPEPL1 MEX3D TRMT1 GRIN2D PIKFYVE MEGF8 EIF4G1 SLC7A5 PRKDC LRBA CEP170B	1.56e-09	1105	231	28	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDKN2A NET1 MYCBP2 EXPH5 ARHGEF17 ARHGEF16 HAUS8 KSR1 SYNJ1 SYNJ2 CLK3 NAV1 PKP2 PPIP5K2 RGL2 TNS3 WDR62 TCF20 PARP8 MEGF8 EIF4G1 CEP152 SH3RF3 CEP170B	4.06e-09	861	231	24	36931259
Pubmed	Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 encoding phosphoribosylpyrophosphate synthetase subunit I and II isoforms.	PRPS2 PRPS1L1 PRPS1	2.89e-07	3	231	3	1314091
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3F TBC1D3 TBC1D3D	1.15e-06	4	231	3	12359748
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3F TBC1D3 TBC1D3D	1.15e-06	4	231	3	8406013
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C	2.86e-06	5	231	3	12604796
Pubmed	Roles of the glutamate receptor epsilon2 and delta2 subunits in the potentiation and prepulse inhibition of the acoustic startle reflex.	GRID2 GRIN2C GRIN2D	2.86e-06	5	231	3	11488959
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3F TBC1D3 TBC1D3D	2.86e-06	5	231	3	8471161
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ARHGEF17 USP19 CRACD RRP12 NAV3 NAV1 RIPOR1 KATNIP ARRDC3 TCF20 MEGF8 TLE4 CEP170B	3.89e-06	407	231	13	12693553
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	PDE7A KREMEN1 MYCBP2 OBSCN RUSC1 DMXL1 FREM2 ST6GAL2 R3HCC1L RECQL4 RIPOR1 NEURL1B HERC2 UNC5D PLXNA3 ITPRIPL2 PGGHG USP24 PTPRU AKR7L CEP152 ADAMTS14 CEP170B	7.26e-06	1215	231	23	15146197
Pubmed	Proteome-wide analysis of phospho-regulated PDZ domain interactions.	NET1 FASTKD5 ARHGEF16 GRIN2C GUCY1A2	8.62e-06	42	231	5	30126976
Pubmed	The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine.	ALKBH5 AXIN2 FTO PLXNA3	2.15e-05	25	231	4	35874829
Pubmed	DNA segments mapped by reciprocal use of microsatellite primers between mouse and rat.	INHA BCL2 SCN2A TG	2.15e-05	25	231	4	8268655
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYCBP2 RUSC1 SYNJ1 NAV1 WDR62 TCF20 USP24 TPGS1 CRK TLE4 ZFHX3 LRBA	2.64e-05	418	231	12	34709266
Pubmed	Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population.	CDKN2A FTO TCF20	3.35e-05	10	231	3	20509872
Pubmed	Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.	CDKN2A BCL2	4.39e-05	2	231	2	23065465
Pubmed	Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.	SCN1A SCN2A	4.39e-05	2	231	2	19694741
Pubmed	The Synaptojanins in the murine small and large intestine.	SYNJ1 SYNJ2	4.39e-05	2	231	2	27878645
Pubmed	Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing.	CACNA1D CACNA1F	4.39e-05	2	231	2	25966695
Pubmed	Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.	GRIN2C GRIN2D	4.39e-05	2	231	2	29317596
Pubmed	NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice.	GRIN2C GRIN2D	4.39e-05	2	231	2	33766086
Pubmed	Cell Differentiation and Aging Lead To Up-Regulation of FTO, While the ALKBH5 Protein Level Was Stable During Aging but Up-Regulated During in vitro-Induced Cardiomyogenesis.	ALKBH5 FTO	4.39e-05	2	231	2	37795886
Pubmed	SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.	SCN1A SCN2A	4.39e-05	2	231	2	30693367
Pubmed	Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.	SCN1A SCN2A	4.39e-05	2	231	2	29649454
Pubmed	[Increased activity of PRPP synthetase].	PRPS2 PRPS1	4.39e-05	2	231	2	18409517
Pubmed	Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.	CDKN2A BCL2	4.39e-05	2	231	2	11804283
Pubmed	Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice.	GRIN2C GRIN2D	4.39e-05	2	231	2	35057644
Pubmed	Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.	SCN1A SCN2A	4.39e-05	2	231	2	33096315
Pubmed	PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness.	PRPS2 PRPS1	4.39e-05	2	231	2	33493137
Pubmed	NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.	GRIN2C GRIN2D	4.39e-05	2	231	2	31786200
Pubmed	Developmentally regulated alternative splicing in a novel synaptojanin.	SYNJ1 SYNJ2	4.39e-05	2	231	2	9442075
Pubmed	Tissue-differential expression of two distinct genes for phosphoribosyl pyrophosphate synthetase and existence of the testis-specific transcript.	PRPS2 PRPS1	4.39e-05	2	231	2	2537655
Pubmed	m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.	ALKBH5 FTO	4.39e-05	2	231	2	34134995
Pubmed	Purkinje cell-specific and inducible gene recombination system generated from C57BL/6 mouse ES cells.	GRID2 GRIN2C	4.39e-05	2	231	2	11243853
Pubmed	Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.	CDKN2A PRKDC	4.39e-05	2	231	2	22135462
Pubmed	Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.	SCN1A SCN2A	4.39e-05	2	231	2	10827969
Pubmed	Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility.	SCN1A DHODH	4.39e-05	2	231	2	31047779
Pubmed	BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.	BCL2 PRKDC	4.39e-05	2	231	2	7669664
Pubmed	Differential expression of two sodium channel subtypes in human brain.	SCN1A SCN2A	4.39e-05	2	231	2	1317301
Pubmed	Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series.	SCN1A SCN2A	4.39e-05	2	231	2	31439038
Pubmed	Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A.	SCN1A SCN2A	4.39e-05	2	231	2	15249644
Pubmed	C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels.	CACNA1D CACNA1F	4.39e-05	2	231	2	16921373
Pubmed	In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.	GRIN2C GRIN2D	4.39e-05	2	231	2	29651654
Pubmed	Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.	GRIN2C GRIN2D	4.39e-05	2	231	2	31110197
Pubmed	Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.	ALKBH5 FTO	4.39e-05	2	231	2	33288560
Pubmed	N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.	ALKBH5 FTO	4.39e-05	2	231	2	27156733
Pubmed	Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.	SCN1A SCN2A	4.39e-05	2	231	2	26311622
Pubmed	Bcl-2 expression promotes B- but not T-lymphoid development in scid mice.	BCL2 PRKDC	4.39e-05	2	231	2	8133891
Pubmed	Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.	BCL2 PRKDC	4.39e-05	2	231	2	8084613
Pubmed	The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe.	SCN1A SCN2A	4.39e-05	2	231	2	21377452
Pubmed	CD3+ T cells in severe combined immunodeficiency (scid) mice. VI. Rescue of scid-derived, IgM-producing B cells by transfer of CD4+ CD8- T cells from various lymphoid organs.	GRID2 PRKDC	4.39e-05	2	231	2	1358814
Pubmed	HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells.	BCL2 GRIN2C GRIN2D	4.59e-05	11	231	3	24739951
Pubmed	Semaphorin-5B Controls Spiral Ganglion Neuron Branch Refinement during Development.	GFI1 PLXNA1 PLXNA3	4.59e-05	11	231	3	31209173
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	CDKN2A NET1 ARHGEF17 ARHGEF16 DDX50 COX5A BRPF1 ARHGAP29 PKP2 PPIP5K2 IPO5 PLEKHG4 NOA1 DUT GRSF1 CRK TNKS2 PSPC1	4.62e-05	916	231	18	32203420
Pubmed	An eIF4E1/4E-T complex determines the genesis of neurons from precursors by translationally repressing a proneurogenic transcription program.	UNC5D TLE4 EIF4G1	6.09e-05	12	231	3	25456498
Pubmed	The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping.	PTPRU AKR7L AKR7A3	6.09e-05	12	231	3	10495887
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYCBP2 USP19 PASK BRPF1 RRP12 RIPOR1 UNC5D WDR62 TCF20 USP24 SMTN EEF2 TLE4 EIF4G1 SLC7A5 PRKDC	6.84e-05	774	231	16	15302935
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CDKN2A CDKN2D SELENOS FASTKD5 AXIN2 PASK DDX50 CLK3 NAV1 PKP2 HERC2 WDR62 KPTN EEF2 TLE4	7.18e-05	695	231	15	23602568
Pubmed	Common type 2 diabetes risk gene variants associate with gestational diabetes.	CDKN2A FTO TCF20	7.87e-05	13	231	3	18984664
Pubmed	Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: a Chinese cohort.	SCN1A SCN2A	1.31e-04	3	231	2	32005694
Pubmed	Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.	CDKN2A PRKDC	1.31e-04	3	231	2	21671477
Pubmed	Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation.	CDKN2A AXIN2	1.31e-04	3	231	2	30504774
Pubmed	Aldo-keto reductase 7A5 (AKR7A5) attenuates oxidative stress and reactive aldehyde toxicity in V79-4 cells.	AKR7L AKR7A3	1.31e-04	3	231	2	24590062
Pubmed	Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.	CDKN2A BCL2	1.31e-04	3	231	2	16273250
Pubmed	Genetic dissection of horizontal cell inhibitory signaling in mice in complete darkness in vivo.	CACNA1D CACNA1F	1.31e-04	3	231	2	26024096
Pubmed	Cocaine preference and neuroadaptations are maintained by astrocytic NMDA receptors in the nucleus accumbens.	GRIN2C GRIN2D	1.31e-04	3	231	2	35867797
Pubmed	Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.	CDKN2A CDKN2D	1.31e-04	3	231	2	12203782
Pubmed	The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.	NUTM2A NUTM2B	1.31e-04	3	231	2	22456610
Pubmed	Sodium channels SCN1A, SCN2A and SCN3A in familial autism.	SCN1A SCN2A	1.31e-04	3	231	2	12610651
Pubmed	Locus-specific DNA methylation in the placenta is associated with levels of pro-inflammatory proteins in cord blood and they are both independently affected by maternal smoking during pregnancy.	GFI1 AHRR	1.31e-04	3	231	2	28820654
Pubmed	Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line.	CDKN2A BCL2	1.31e-04	3	231	2	23673926
Pubmed	Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.	AKR7L AKR7A3	1.31e-04	3	231	2	12071861
Pubmed	Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.	SCN1A SCN2A	1.31e-04	3	231	2	18784617
Pubmed	Differential expression of plexin-A subfamily members in the mouse nervous system.	PLXNA1 PLXNA3	1.31e-04	3	231	2	11241833
Pubmed	Gene Polymorphism Association with Type 2 Diabetes and Related Gene-Gene and Gene-Environment Interactions in a Uyghur Population.	CDKN2A FTO	1.31e-04	3	231	2	26873362
Pubmed	Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.	NAV3 NAV1	1.31e-04	3	231	2	15158073
Pubmed	Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.	SCN1A SCN2A	1.31e-04	3	231	2	28518218
Pubmed	Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2.	BCL2 COX5A	1.31e-04	3	231	2	19834492
Pubmed	RUVBL2 is a novel repressor of ARF transcription.	CDKN2A CDKN2D	1.31e-04	3	231	2	22285491
Pubmed	Fat mass and obesity-associated protein (FTO) mediated m6A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay.	FTO SLC7A5	1.31e-04	3	231	2	38556586
Pubmed	The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.	CDKN2A PRKDC	1.31e-04	3	231	2	21209895
Pubmed	Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase.	PRPS2 PRPS1	1.31e-04	3	231	2	26175007
Pubmed	Auditory pathway and auditory brainstem response in mice lacking NMDA receptor epsilon 1 and epsilon 4 subunits.	GRIN2C GRIN2D	1.31e-04	3	231	2	9718984
Pubmed	Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.	SCN1A SCN2A	1.31e-04	3	231	2	32185219
Pubmed	[Purification of recombinant AKR7A5 protein and measurement of substrate specificity of AKR7A5 towards naphthoquinone and its derivatives].	AKR7L AKR7A3	1.31e-04	3	231	2	22863590
Pubmed	SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.	SCN1A SCN2A	1.31e-04	3	231	2	23859570
Pubmed	Partial reconstitution of mammalian phosphoribosylpyrophosphate synthetase in Escherichia coli cells. Coexpression of catalytic subunits with the 39-kDa associated protein leads to formation of soluble multimeric complexes of various compositions.	PRPS2 PRPS1	1.31e-04	3	231	2	9366267
Pubmed	Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytes.	CDKN2A CDKN2D	1.31e-04	3	231	2	21789189
Pubmed	Diversity of human copy number variation and multicopy genes.	TBC1D3G TBC1D3E	1.31e-04	3	231	2	21030649
Pubmed	Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.	CDKN2A CDKN2D	1.31e-04	3	231	2	9751050
Pubmed	Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.	AKR7L AKR7A3	1.31e-04	3	231	2	12123834
Pubmed	Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.	BCL2 MEX3D	1.31e-04	3	231	2	29066822
Pubmed	p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.	CDKN2A CDKN2D	1.31e-04	3	231	2	27664376
Pubmed	Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma.	PRPS2 PRPS1	1.31e-04	3	231	2	32391636
Pubmed	Correlation of nuclear morphometry of primary melanoma of the skin with clinicopathological parameters and expression of tumor suppressor proteins (p53 and p16(INK4a)) and bcl-2 oncoprotein.	CDKN2A BCL2	1.31e-04	3	231	2	23818364
Pubmed	Cloning of cDNAs for human phosphoribosylpyrophosphate synthetases 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes.	PRPS2 PRPS1	1.31e-04	3	231	2	1962753
Pubmed	Nav1.2 is expressed in caudal ganglionic eminence-derived disinhibitory interneurons: Mutually exclusive distributions of Nav1.1 and Nav1.2.	SCN1A SCN2A	1.31e-04	3	231	2	28784306
Pubmed	Identification of plexin family molecules in mice.	PLXNA1 PLXNA3	1.31e-04	3	231	2	8806646
Interaction	FIBIN interactions	MAN2A2 CHST12 PLXNA1 TRHDE PLXNA3 PTPRU MEGF8 CHRD	1.20e-06	71	224	8	int:FIBIN
Interaction	YWHAH interactions	CDKN2A NET1 MYCBP2 EXPH5 ARHGEF17 ARHGEF16 HAUS8 KSR1 SYNJ1 SYNJ2 CLK3 RECQL4 NAV1 PKP2 PPIP5K2 RGL2 TNS3 WDR62 TCF20 PARP8 MEX3D CNTRL CRK CCNF MEGF8 EIF4G1 CEP152 LRBA SH3RF3 CEP170B	5.29e-06	1102	224	30	int:YWHAH
Interaction	YWHAB interactions	CDKN2A PDE7A MYCBP2 EXPH5 ARHGEF17 ARHGEF16 KSR1 NFATC2 SYNJ2 CLK3 RECQL4 FER NAV1 PKP2 PPIP5K2 RGL2 VWA2 SAP130 TNS3 WDR62 IPO5 NGB PARP8 CRK CCNF EIF4G1 SH3RF3 CEP170B	8.64e-06	1014	224	28	int:YWHAB
Interaction	PRG2 interactions	THSD4 MAN2A2 HS6ST2 ST14 PASK CHST12 PLXNA1 PLEKHG4 VWA1 PTPRU CHRD ADAMTS14 SPEM1	1.95e-05	285	224	13	int:PRG2
Interaction	YWHAG interactions	CDKN2A NET1 MYCBP2 EXPH5 ARHGEF17 ARHGEF16 CRACD HAUS8 KSR1 SYNJ1 NFATC2 SYNJ2 CLK3 RECQL4 ARHGAP29 NAV1 PKP2 PPIP5K2 RGL2 TNS3 WDR62 NGB PARP8 USP24 CRK CCNF EIF4G1 PRKDC LRBA SH3RF3 CEP170B	2.23e-05	1248	224	31	int:YWHAG
Interaction	MFAP4 interactions	THSD4 MAN2A2 HS6ST2 CHST12 PLXNA1 PLXNA3 PTPRU TLE4 CHRD	2.59e-05	139	224	9	int:MFAP4
Interaction	TOP3B interactions	LZTR1 MAN2A2 MYCBP2 OBSCN ABCA7 ST14 RYR1 AXIN2 URB1 SYNJ1 RRP12 NAV1 PKP2 RIPOR1 HERC2 RGL2 PLXNA1 MOV10 IPO5 PLXNA3 ITPRIPL2 RNPEPL1 MEX3D TRMT1 GRIN2D GRSF1 PIKFYVE CCNF MEGF8 EIF4G1 SLC7A5 PRKDC LRBA CEP170B	3.70e-05	1470	224	34	int:TOP3B
Interaction	GOLGA1 interactions	LZTR1 DMXL1 PASK R3HCC1L ARHGAP29 PPP1R37 NAV1 USP24 CEP152 CEP170B	3.99e-05	183	224	10	int:GOLGA1
Interaction	HLA-G interactions	MAN2A2 HS6ST2 ST14 CHST12 PLXNA1 PLXNA3 PTPRU MEGF8	5.27e-05	118	224	8	int:HLA-G
Interaction	DNASE1L1 interactions	THSD4 MAN2A2 ST14 PLXNA1 PLXNA3 MEGF8 CHRD ADAMTS14	5.94e-05	120	224	8	int:DNASE1L1
Interaction	BTNL2 interactions	THSD4 MAN2A2 HS6ST2 ST14 CHST12 PLXNA1 PLXNA3 PTPRU MEGF8	6.09e-05	155	224	9	int:BTNL2
Interaction	WDR83 interactions	NET1 FRS3 ARHGEF17 TBC1D3F TBC1D3 CNTRL TBC1D3B CRK PIKFYVE CEP152	7.12e-05	196	224	10	int:WDR83
Interaction	GIPC3 interactions	ST6GAL2 MOV10 GIPC3	7.28e-05	8	224	3	int:GIPC3
Interaction	SLC16A1 interactions	RECQL4 COQ9 ARRDC3 HERC2 PLEKHG4 CNTRL GRM2 CCNF EEF2 SLC7A5	8.42e-05	200	224	10	int:SLC16A1
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	GPR179 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.71e-11	149	231	12	chr17q12
Cytoband	19p13.3	LINGO3 ABCA7 MEX3D TPGS1 BTBD2 GIPC3 EEF2 GTF2F1 EBI3	3.65e-06	237	231	9	19p13.3
Cytoband	12q15-q21	PTPRB TRHDE	7.54e-05	3	231	2	12q15-q21
Cytoband	17q12	TBC1D3F TBC1D3 TBC1D3H TBC1D3C TBC1D3B	1.50e-04	99	231	5	17q12
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	CDKN2D ZNF627 LINGO3 ABCA7 HAUS8 MEX3D TRMT1 TPGS1 BTBD2 GIPC3 EEF2 GTF2F1 EBI3	2.26e-04	797	231	13	chr19p13
GeneFamily	Fibronectin type III domain containing	OBSCN PTPRB SDK2 VWA1 PTPRU EBI3 LRRN4 ANKFN1	3.51e-05	160	140	8	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN LINGO3 HMCN2 PXDNL MYPN UNC5D SDK2 SIGLEC16	3.67e-05	161	140	8	593
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NET1 OBSCN ARHGEF17 ARHGEF16 PLEKHG4	1.58e-04	66	140	5	722
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2C GRIN2D	1.22e-03	7	140	2	1201
GeneFamily	Alkylation repair homologs	ALKBH5 FTO	2.07e-03	9	140	2	401
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 LRBA	2.07e-03	9	140	2	1230
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN1A SCN2A	2.07e-03	9	140	2	1203
GeneFamily	Plexins	PLXNA1 PLXNA3	2.07e-03	9	140	2	683
Coexpression	GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	PDE7A KREMEN1 ARHGAP29 UNC79 SDK2 SYNM NFAM1 PDLIM4 ADAMTS14 PIK3R5	1.16e-06	155	229	10	M8913
Coexpression	SOGA_COLORECTAL_CANCER_MYC_UP	PRPS2 PRPS1L1 ADSL DHODH DUT ASNS SLC7A5	7.73e-06	82	229	7	M45007
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	CDKN2A GIPC2 ARHGEF17 ST14 SVEP1 FREM2 PTPRB NFATC2 ARHGAP29 PKP2 PIF1 TNS3 TRHDE FAT4 ITPRIPL2 GRIN2C PTPRU LFNG GIPC3 LPL NR2E1 CHRD IGSF21 PIK3R5 B3GAT2	8.79e-06	1074	229	25	M1941
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CDKN2D ABCA3 PDE7A MYCBP2 HS6ST2 NUTM2A FRS3 RUSC1 ST6GAL2 SYNJ1 SCN1A SCN2A ANKAR NAV3 NAV1 UNC79 PLXNA1 TRHDE PLXNA3 TBC1D3 GRID2 IKZF4 ASNS ZFHX3 CDH4	1.44e-05	1106	229	25	M39071
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	PAOX FREM2 TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	2.69e-09	90	223	11	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	SPATA7 ABCA3 MAN2A2 HS6ST2 ARHGEF17 ABCA7 FREM2 CLK3 NAV1 RIPOR1 TBC1D3G UNC5D TNS3 MOV10 TBC1D3K TBC1D3F DXO SDK2 TBC1D3 TBC1D3H TBC1D3L PCDHGC4 TBC1D3D TBC1D3C TBC1D3B LFNG PDLIM4 TLE4 IGSF21	3.10e-06	1075	223	29	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L PGGHG TBC1D3D SYNM TBC1D3C TBC1D3B PIK3R5	1.03e-05	242	223	12	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RYR1 STAB1 NFATC2 RECQL4 PIF1 WDR62 CNTRL WDFY4 CCNF IGSF21 PIK3R5	4.23e-09	187	231	11	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FREM2 SCN2A NAV3 UNC79 UNC5D TRHDE CACNA1F FAT4	5.32e-07	184	231	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FREM2 SCN2A NAV3 UNC79 UNC5D TRHDE CACNA1F FAT4	5.32e-07	184	231	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FREM2 SCN2A NAV3 UNC79 UNC5D TRHDE CACNA1F FAT4	5.32e-07	184	231	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDE7A EXPH5 HS6ST2 FREM2 UNC79 TCF20 PARP8 IKZF4 TLE4	6.37e-07	188	231	9	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE7A BCL2 GFI1 NFATC2 NLRC3 PARP8 TG SLC7A5 PIK3R5	1.07e-06	200	231	9	8474e5d031d25bfb8461d39fa2053da01a6304fc
ToppCell	(09)_Ionocytes-(3)_72hpi\|(09)_Ionocytes / shred by cell type and Timepoint	PDE7A BCL2 VWA2 USP24 FADS1 TLE4 PSPC1	1.74e-06	110	231	7	fce7d5a0617fc664b657f5bb9abb290e7cc234cb
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPATA7 STAB1 SCN1A PIF1 WDR62 IKZF4 CEP152 PRPS1	2.35e-06	164	231	8	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPATA7 STAB1 SCN1A PIF1 WDR62 IKZF4 CEP152 PRPS1	2.35e-06	164	231	8	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	facs-Liver-Non-hepatocytes-24m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN2D PDE7A BCL2 GFI1 NLRC3 TG ADAMTS14 RINL	2.81e-06	168	231	8	1254c66f0cd53ef3b913933c0b0648d091da07e9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ST6GAL2 RASSF3 NEURL1B UNC5D TRHDE NGB GUCY1A2 PLCH2	3.07e-06	170	231	8	3174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	SLC15A3 ABCA7 SLC26A1 STAB1 NAV1 KATNIP GRIN2D MEGF8	3.34e-06	172	231	8	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NET1 SLC15A3 CRACD RASSF3 ITPRIPL2 WDFY4 LPL PNPLA7	3.96e-06	176	231	8	e74ad0db3b05897edcfabeb11008ede2b9eeb638
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NET1 SLC15A3 CRACD RASSF3 ITPRIPL2 WDFY4 LPL PNPLA7	4.13e-06	177	231	8	71919b5c9bfa87fdd2cd44dfa057b66ea081be5d
ToppCell	droplet-Lung-LUNG-1m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 SLC15A3 CRACD RASSF3 NFAM1 WDFY4 LPL PNPLA7	5.73e-06	185	231	8	53a5218c1e6eb12daccde3d6e02f337e2586d74c
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2A2 STAB1 PTPRB NOTCH4 TNS3 GUCY1A2 CHRD LRBA	5.96e-06	186	231	8	37860daeecd6d412bd3797f30496a56da667fbd1
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2A2 STAB1 PTPRB NOTCH4 TNS3 GUCY1A2 CHRD LRBA	5.96e-06	186	231	8	60830822d3de3147816693404fd03392e04c2b8e
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2A2 STAB1 PTPRB NOTCH4 TNS3 GUCY1A2 CHRD LRBA	5.96e-06	186	231	8	baebeffdd426ce767190ddefc857cc78e6a58d36
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	OBSCN ARHGEF17 NEURL1B UNC5D SYNM SMTN GUCY1A2 SH3RF3	6.20e-06	187	231	8	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	OBSCN ARHGEF17 AHRR SYNM SMTN GUCY1A2 LPL ADAMTS14	6.20e-06	187	231	8	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CRACD PTPRB SYNJ2 NAV1 NOTCH4 EVA1C LPL ASNS	6.70e-06	189	231	8	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BCL2 SVEP1 CACNA1D SDK2 GRID2 FADS1 GUCY1A2 KIAA1755	6.96e-06	190	231	8	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	CF-Lymphoid-B_cell\|CF / Disease state, Lineage and Cell class	MYCBP2 FCRL3 NFATC2 CNTRL WDFY4 PIKFYVE EBI3 LRBA	6.96e-06	190	231	8	374d8fd63c733178acab07682ed1519693efab45
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GIPC2 CRACD PTPRB SYNJ2 NAV1 NOTCH4 EVA1C ASNS	6.96e-06	190	231	8	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 ARHGEF17 SVEP1 CRACD NEURL1B GUCY1A2 KIAA1755 SH3RF3	6.96e-06	190	231	8	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	NAIP STAB1 TNS3 PARP8 WDFY4 EBI3 IGSF21 PIK3R5	7.23e-06	191	231	8	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NET1 NGB VWA1 PDLIM4 SMTN CHRD ADAMTS14 CDH4	7.52e-06	192	231	8	93903576dddd8227328e4ced75aa7625eedb9baf
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NET1 NGB VWA1 PDLIM4 SMTN CHRD ADAMTS14 CDH4	7.81e-06	193	231	8	cfab88935abe0a15632c5eec8ff00a857ec9b3ed
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD4 PTPRB ARHGAP29 NAV1 NEURL1B NOTCH4 RP1L1 SH3RF3	7.81e-06	193	231	8	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	MYCBP2 BCL2 FCRL3 FER RASSF3 WDFY4 PIKFYVE EBI3	7.81e-06	193	231	8	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL TRHDE CACNA1D SDK2 GRID2 GUCY1A2 KIAA1755	8.11e-06	194	231	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A ARRDC3 USP24 LPL LRBA	8.42e-06	195	231	8	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STAB1 NFATC2 RASSF3 PARP8 CNTRL WDFY4 IGSF21 PIK3R5	8.42e-06	195	231	8	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	10x5'-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	NAIP ARHGEF17 STAB1 TDRD6 PCDHGC4 PTPRU WDFY4	9.06e-06	141	231	7	7671d300b1722711fd2d8034b96a3aa7e3ccb560
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 NFATC2 TNS3 FAT4 GUCY1A2 KIAA1755 SH3RF3	9.07e-06	197	231	8	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 NFATC2 TNS3 FAT4 GUCY1A2 KIAA1755 SH3RF3	9.07e-06	197	231	8	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	ASK428-Endothelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	GIPC2 STAB1 PTPRB ARHGAP29 NOTCH4 FAT4 SYNM SMTN	9.41e-06	198	231	8	d69d0ff115298596173a4278897a65007a71f5df
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NET1 AXIN2 PTPRB ARHGAP29 VWA2 NOTCH4 SMTN SLC7A5	9.76e-06	199	231	8	236b1417ed0875e98c6ec1ec714003bfce438d65
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IDI2-AS1 ST6GAL2 SCN1A SCN2A NAV1 UNC79 USP24 IGSF21	9.76e-06	199	231	8	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAIP RYR1 STAB1 NFAM1 WDFY4 EBI3 IGSF21 PIK3R5	1.01e-05	200	231	8	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NET1 PTPRB ARHGAP29 VWA2 NOTCH4 VWA1 SMTN SLC7A5	1.01e-05	200	231	8	86ec951234015ced7126b016199e5869a0f22478
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLCXD2 BCL2 GFI1 NFATC2 NLRC3 PARP8 SLC7A5 PIK3R5	1.01e-05	200	231	8	66fb892bda1d29e67a65717e85f2ec221f520b2a
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CDKN2A PLCXD2 KATNIP UNC79 TG CCNF ADAMTS14	2.06e-05	160	231	7	6b0faaa371650563f585722f5b2fb319e124ec38
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NET1 MYCBP2 WDFY4 WDR87 LPL RP1L1 PNPLA7	2.23e-05	162	231	7	d712bc31840ad1523e3dbf884acbb428a8995001
ToppCell	Healthy_Control-Lymphoid-Plasma-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PASK PKP2 PGGHG EVA1C ASNS KCNMB3 ADAMTS14	2.32e-05	163	231	7	b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PASK PKP2 PGGHG EVA1C ASNS KCNMB3 ADAMTS14	2.32e-05	163	231	7	2913ccdd4613472cd82077d4993e1d9f8b223398
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AHRR PTPRB HMCN2 SYNJ2 NAV1 NOTCH4 EVA1C	2.51e-05	165	231	7	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIPC2 EXPH5 ST14 PKP2 GRIN2D PRKDC SH3RF3	2.61e-05	166	231	7	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB RYR1 NFATC2 PGGHG BTBD17 WDFY4 EBI3	2.61e-05	166	231	7	c215c4aede38d355d35fd26cd7ef2c19efecd0e6
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIPC2 EXPH5 ST14 PKP2 GRIN2D PRKDC SH3RF3	2.61e-05	166	231	7	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	THSD4 OBSCN ARHGAP29 NOTCH4 SYNM GIPC3 SH3RF3	2.71e-05	167	231	7	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXNA1 CACNA1F NFAM1 WDFY4 PDLIM4 EBI3 LPL	2.81e-05	168	231	7	04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB RYR1 NFATC2 PGGHG BTBD17 WDFY4 EBI3	2.92e-05	169	231	7	735655e75511c5c41aca667909e8bb52a0ad7fc6
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	THSD4 OBSCN STAB1 MYPN WDFY4 TG PIK3R5	3.04e-05	170	231	7	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-mature_conventional_dendritic_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ST6GAL2 NAV1 NEURL1B VWA1 PDLIM4 EBI3 ANKFN1	3.15e-05	171	231	7	d934d68efc5739483c735dc702ccd30b07a6aa7e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LPL	3.39e-05	173	231	7	0c74bdb40e635d906fd180412c23bf7fed61621e
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	OBSCN ARHGEF17 NEURL1B UNC5D SYNM GUCY1A2 CHRD	3.39e-05	173	231	7	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	KREMEN1 NAIP ANKAR TPGS1 EBI3 LPL	3.50e-05	118	231	6	7e6cb77fa9154f2da985c455bb6a24d6029cc8d6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EXPH5 SVEP1 AHRR PKP2 FAT4 GRIN2D NR2E1	3.93e-05	177	231	7	84116796ca4c7007508c0f1a68a1135c7b922278
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB SYNJ2 NAV1 NOTCH4 FAT4 TBC1D3L EVA1C	4.07e-05	178	231	7	5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF17 GPR179 NEURL1B UNC5D SDK2 SMTN GUCY1A2	4.22e-05	179	231	7	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF17 GPR179 NEURL1B UNC5D SDK2 SMTN GUCY1A2	4.22e-05	179	231	7	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GIPC2 TMEM52B ST14 TRHDE PGGHG SI AKR7A3	4.37e-05	180	231	7	8d9be9cfdf98e5888654a28ab12e5e89f201af00
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	THSD4 ST6GAL2 PXDNL SYNM SMTN ZFHX3 SH3RF3	4.37e-05	180	231	7	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD PKP2 FAT4 SDK2 GRIN2D NR2E1 ANKFN1	4.37e-05	180	231	7	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNJ2 VWA2 SDK2 PTPRU TLE4 ZFHX3 PNPLA7	4.37e-05	180	231	7	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 SVEP1 PTPRB NAV3 NAV1 FAT4 VWA1	4.37e-05	180	231	7	12537d8a569faa69f474284d2c201475722b8ca1
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD PKP2 FAT4 SDK2 GRIN2D NR2E1 ANKFN1	4.69e-05	182	231	7	7dc61e901428cea04f00ebb0939a44d21a6145c6
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 PTPRB NAV1 NOTCH4 TNS3 PCDHGA1 PTPRU	4.69e-05	182	231	7	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 PTPRB NAV1 NOTCH4 TNS3 PCDHGA1 PTPRU	4.69e-05	182	231	7	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SVEP1 CRACD FREM2 PKP2 VWA5B1 GRID2 NR2E1	4.69e-05	182	231	7	724c33ad2fb525cbcfa5efa3362675eb42a5636d
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	OBSCN ARHGEF17 UNC5D SYNM SMTN GUCY1A2 SH3RF3	4.85e-05	183	231	7	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	THSD4 PDE7A OBSCN PXDNL MYPN PKP2 LPL	5.02e-05	184	231	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD PKP2 FAT4 SDK2 GRIN2D NR2E1 ANKFN1	5.20e-05	185	231	7	08fad1e3c3cc5f1c3eb6629a49c094b628e75a92
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	SVEP1 HMCN2 NAV3 NAV1 CACNA1D GUCY1A2 KIAA1755	5.20e-05	185	231	7	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SCN1A UNC79 UNC5D CNTF GRIN2C ANKFN1 SPEM1	5.38e-05	186	231	7	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PTPRB HMCN2 ARHGAP29 TDRD6 NEURL1B NOTCH4 VWA1	5.38e-05	186	231	7	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	COVID-19_Mild-Neu_4\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	SVEP1 RECQL4 PIF1 CNTRL DUT LFNG CCNF	5.56e-05	187	231	7	714851e757c71c559ee6413a3f61d6c117c79ad2
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	EXPH5 CRACD FREM2 TCF20 PGGHG TLE4 SH3RF3	5.56e-05	187	231	7	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SVEP1 CRACD RASSF3 TNS3 SDK2 NR2E1 CDH4	5.56e-05	187	231	7	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LRBA	5.75e-05	188	231	7	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LRBA	5.75e-05	188	231	7	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LRBA	5.95e-05	189	231	7	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	ARHGEF17 PXDNL ARHGAP29 NOTCH4 SYNM GUCY1A2 LPL	5.95e-05	189	231	7	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LRBA	5.95e-05	189	231	7	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 SLC15A3 CRACD ITPRIPL2 WDFY4 LPL PNPLA7	5.95e-05	189	231	7	287e59104687fe1665232c52993889f0f2c97f17
ToppCell	droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 SLC15A3 CRACD ITPRIPL2 WDFY4 LPL PNPLA7	5.95e-05	189	231	7	6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LRBA	5.95e-05	189	231	7	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PTPRB HMCN2 SYNJ2 NAV1 NOTCH4 EVA1C	5.95e-05	189	231	7	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	OBSCN ARHGEF17 SYNM SMTN GUCY1A2 LPL ADAMTS14	5.95e-05	189	231	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NAIP RYR1 STAB1 WDFY4 IGSF21 PIK3R5 SLC38A6	5.95e-05	189	231	7	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HS6ST2 TMEM52B PXDNL SCN2A CACNA1D USP24 LRBA	6.15e-05	190	231	7	b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SLC15A3 STAB1 NAV1 PKP2 ITPRIPL2 ZFHX3 IGSF21	6.15e-05	190	231	7	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 HS6ST2 TMEM52B SCN2A CACNA1D USP24 LRBA	6.15e-05	190	231	7	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OBSCN PXDNL MYPN NAV1 PKP2 SYNM LPL	6.15e-05	190	231	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR1 STAB1 NFATC2 WDFY4 EBI3 IGSF21 PIK3R5	6.15e-05	190	231	7	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ARHGEF17 PTPRB ARHGAP29 NEURL1B NOTCH4 GUCY1A2 ZFHX3	6.15e-05	190	231	7	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 CRACD NEURL1B GUCY1A2 ANKFN1 SH3RF3	6.35e-05	191	231	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SLC15A3 RYR1 STAB1 GRIN2C WDFY4 EBI3 PIK3R5	6.35e-05	191	231	7	c383ae386bc53e73a683a9543c7dfed2a65257c5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR1 STAB1 NFATC2 WDFY4 EBI3 IGSF21 PIK3R5	6.35e-05	191	231	7	baa70781633a3fe5bf987f9d8dff3884f5167e7f
Drug	riluzole	RYR1 ADSL NAV1 CNTF CACNA1D CACNA1F GRID2 GRIN2C GRIN2D GRM2 PDLIM4	1.29e-06	174	224	11	CID000005070
Drug	C-PP	DUT GRID2 GRIN2C GRIN2D GRM2	7.20e-06	28	224	5	CID000001228
Drug	AC1L9828	PRPS2 DUT PRPS1	9.26e-06	5	224	3	CID000439794
Drug	methyl iodoacetate	PRPS2 PRPS1L1 PRPS1	1.84e-05	6	224	3	CID006429536
Drug	APP-MP	PRPS2 PRPS1L1 PRPS1	1.84e-05	6	224	3	CID003081102
Drug	pyrimidine-5-nucleotide	PRPS2 PRPS1L1 PRPS1	1.84e-05	6	224	3	CID000440040
Drug	NDPhA	CYP2E1 AHRR PLXNA3 SYNM	1.96e-05	17	224	4	CID000006838
Drug	1tjp	OBSCN BCL2 PKP2 DUT GRIN2C GRIN2D SMTN CHRD	1.98e-05	116	224	8	CID005459371
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	LZTR1 ABCA7 GFI1 PAOX SYNJ2 PLXNA1 IPO5 CACNA1D TAF1C TNKS2	2.26e-05	193	224	10	4161_DN
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HT_HG-U133A	CDKN2D FRS3 BCL2 SVEP1 USP19 PAOX SYNJ2 PLXNA1 CNTRL ZFHX3	2.58e-05	196	224	10	6313_UP
Drug	R,S)-AMPA	DUT GRID2 GRIN2C GRIN2D GRM2	2.59e-05	36	224	5	CID000001221
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	MAN2A2 ARHGEF17 ARHGEF16 RYR1 STAB1 R3HCC1L PTPRB PARP8 GRM2 TLE4	2.82e-05	198	224	10	4278_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	CDKN2A ABCA7 GFI1 STAB1 KSR1 SYNJ1 SYNJ2 PKP2 TAF1C SMTN	2.82e-05	198	224	10	5220_UP
Drug	6-aminochrysene	CYP2E1 AHRR SYNM SLC38A6	3.15e-05	19	224	4	CID000017534
Drug	L-BMAA	GRID2 GRIN2C GRIN2D GRM2 SLC7A5	3.40e-05	38	224	5	CID000028558
Drug	4CPG	GRID2 GRIN2C GRIN2D GRM2 SLC7A5	3.40e-05	38	224	5	CID000005115
Disease	Colorectal Carcinoma	ZDHHC2 ABCA3 OBSCN BCL2 AXIN2 VWA2 RNPEPL1 PARP8 GRID2 PTPRU SMTN FADS1 GUCY1A2 EIF4G1 IGSF21 PIK3R5 PRPS1	2.19e-05	702	219	17	C0009402
Disease	autism spectrum disorder (implicated_via_orthology)	ABCA3 SCN1A SCN2A PKP2 TCF20 SLC7A5 LRBA	1.47e-04	152	219	7	DOID:0060041 (implicated_via_orthology)
Disease	neurilemmoma (is_implicated_in)	CDKN2A LZTR1	1.64e-04	3	219	2	DOID:3192 (is_implicated_in)
Disease	rectum adenocarcinoma (is_marker_for)	EEF2 SLC7A5	1.64e-04	3	219	2	DOID:1996 (is_marker_for)
Disease	creatinine measurement	SPATA7 GIPC2 PDE7A OBSCN BCL2 ST14 RYR1 ADSL MYPN NLRC3 LFNG FAM135B PDLIM4 FADS1 LPL KIAA1755 ZFHX3 PNPLA7 IGSF21	1.72e-04	995	219	19	EFO_0004518
Disease	Autoimmune thyroiditis	FCRL3 TG	3.26e-04	4	219	2	C0920350
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1D CACNA1F	3.26e-04	4	219	2	DOID:0060173 (implicated_via_orthology)
Disease	dysgerminoma (is_marker_for)	INHA ST14	3.26e-04	4	219	2	DOID:4441 (is_marker_for)
Disease	Malignant neoplasm of breast	CDKN2A ABCA3 NET1 OBSCN BCL2 ACY1 FCRL3 SYNJ2 ARHGAP29 ARRDC3 HERC2 FTO NOTCH4 NOA1 GRIN2D EEF2 GUCY1A2 LRBA PRPS1	4.45e-04	1074	219	19	C0006142
Disease	orofacial cleft, sex interaction measurement	EXPH5 ST14 NOTCH4 TNS3 ZFHX3	4.60e-04	86	219	5	EFO_0008343, MONDO_0000358
Disease	cholelithiasis	ADSL SYNJ2 FTO FADS1 LRBA	5.11e-04	88	219	5	EFO_0004799
Disease	Insulinogenic index measurement	MYCBP2 PPIP5K2	5.40e-04	5	219	2	EFO_0009961
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	5.40e-04	5	219	2	C0206630
Disease	airway responsiveness measurement	USP24 WDFY4 ANKFN1	7.27e-04	24	219	3	EFO_0006897
Disease	glioblastoma (is_implicated_in)	CDKN2A LZTR1 PTPRB	7.27e-04	24	219	3	DOID:3068 (is_implicated_in)
Disease	triacylglycerol 52:2 measurement	PTPRU TG FADS1 LPL	7.49e-04	55	219	4	EFO_0010414
Disease	early-onset Parkinson's disease (implicated_via_orthology)	SYNJ1 SYNJ2	8.07e-04	6	219	2	DOID:0060894 (implicated_via_orthology)
Disease	muscular disease (is_implicated_in)	CPT2 LPL	8.07e-04	6	219	2	DOID:0080000 (is_implicated_in)
Disease	obesity (biomarker_via_orthology)	CDKN2A CYP2E1 BCL2 FTO FADS1 LPL	8.28e-04	147	219	6	DOID:9970 (biomarker_via_orthology)
Disease	Schizophrenia	KREMEN1 CYP2E1 RTN4R FASTKD5 BCL2 NAV1 CNTF NOTCH4 IPO5 CACNA1F GRIN2C GRIN2D GRM2 LPL NR2E1 B3GAT2	9.79e-04	883	219	16	C0036341
Disease	Seizure, Febrile, Complex	SCN1A SCN2A	1.12e-03	7	219	2	C0751057
Disease	Seizure, Febrile, Simple	SCN1A SCN2A	1.12e-03	7	219	2	C0149886
Disease	Parkinson's disease (implicated_via_orthology)	GIPC2 AXIN2 SYNJ1 SYNJ2 GIPC3 EIF4G1	1.16e-03	157	219	6	DOID:14330 (implicated_via_orthology)
Disease	tumor necrosis factor receptor superfamily member 19L measurement	ARHGEF17 PIKFYVE	1.49e-03	8	219	2	EFO_0008309
Disease	triacylglycerol 54:3 measurement	MYPN FADS1 LPL	1.55e-03	31	219	3	EFO_0010421
Disease	neutrophil count	CDKN2A MYCBP2 NAIP BCL2 ABCA7 CEPT1 ADSL COX5A RRP12 CHST12 RASSF3 FTO NOTCH4 TNS3 PARP8 CRK FADS1 RP1L1 PRKDC LRBA TNKS2	1.56e-03	1382	219	21	EFO_0004833
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	FTO FADS1 LPL ZFHX3	1.75e-03	69	219	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	Adenocarcinoma	CDKN2A CYP2E1 BCL2 FAT4 EEF2	1.77e-03	116	219	5	C0001418
Disease	Carcinoma, Granular Cell	CDKN2A CYP2E1 BCL2 FAT4 EEF2	1.77e-03	116	219	5	C0205644
Disease	Adenocarcinoma, Tubular	CDKN2A CYP2E1 BCL2 FAT4 EEF2	1.77e-03	116	219	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	CDKN2A CYP2E1 BCL2 FAT4 EEF2	1.77e-03	116	219	5	C0205642
Disease	Carcinoma, Cribriform	CDKN2A CYP2E1 BCL2 FAT4 EEF2	1.77e-03	116	219	5	C0205643
Disease	Adenocarcinoma, Basal Cell	CDKN2A CYP2E1 BCL2 FAT4 EEF2	1.77e-03	116	219	5	C0205641
Disease	Generalized Epilepsy with Febrile Seizures Plus	SCN1A SCN2A	1.91e-03	9	219	2	C3502809
Disease	Febrile Convulsions	SCN1A SCN2A	1.91e-03	9	219	2	C0009952
Disease	Myoclonic Epilepsy	HEXB SCN1A	1.91e-03	9	219	2	C0014550
Disease	glycoprotein measurement	DHODH POM121L2 LPL ZFHX3 CDH4	1.98e-03	119	219	5	EFO_0004555
Disease	Grey matter density measurement	SCN1A KATNIP GUCY1A2	2.04e-03	34	219	3	EFO_0010306
Disease	Spinocerebellar Ataxia Type 4	GFI1 PLEKHG4 GRID2	2.22e-03	35	219	3	C0752122
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN1A SCN2A	2.37e-03	10	219	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN1A SCN2A	2.37e-03	10	219	2	DOID:0080422 (implicated_via_orthology)
Disease	glaucoma (is_implicated_in)	CNTF EEF2	2.37e-03	10	219	2	DOID:1686 (is_implicated_in)
Disease	urate measurement, bone density	THSD4 NAV1 FTO NOTCH4 GRIN2C THAP9 TG KIAA1755 PRKDC CDH4 SH3RF3 B3GAT2	2.41e-03	619	219	12	EFO_0003923, EFO_0004531
Disease	colorectal carcinoma (is_marker_for)	SELENOS AXIN2 PTPRB	2.60e-03	37	219	3	DOID:0080199 (is_marker_for)
Disease	granulosa cell tumor (is_marker_for)	CDKN2A ST14	2.89e-03	11	219	2	DOID:2999 (is_marker_for)
Disease	Bipolar I disorder	BCL2 NR2E1	2.89e-03	11	219	2	C0853193
Disease	polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement	LCLAT1 ZFHX3	2.89e-03	11	219	2	EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Disease	cysteine-glutathione disulfide measurement	NFAM1 SH3RF3	2.89e-03	11	219	2	EFO_0021001
Disease	Night blindness, congenital stationary, type 1	GPR179 CACNA1F	3.45e-03	12	219	2	C3501847
Disease	metabolite measurement, body weight gain	FADS1 ZFHX3	3.45e-03	12	219	2	EFO_0004566, EFO_0004725
Disease	Night Blindness, Congenital Stationary, Type 1A	GPR179 CACNA1F	3.45e-03	12	219	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	GPR179 CACNA1F	3.45e-03	12	219	2	C1864877
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN1A SCN2A	3.45e-03	12	219	2	DOID:0060170 (implicated_via_orthology)
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GPR179 CACNA1F	3.45e-03	12	219	2	C1850362
Disease	X-Linked Csnb	GPR179 CACNA1F	3.45e-03	12	219	2	C3711543
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	GPR179 CACNA1F	3.45e-03	12	219	2	C1848172
Disease	Agents acting on the renin-angiotensin system use measurement	SVEP1 NFATC2 FTO SAP130 CNTF CACNA1D LFNG CRK	3.71e-03	335	219	8	EFO_0009931
Disease	pulse pressure measurement	THSD4 SVEP1 NFATC2 PXDNL MYPN FER NAV1 NEURL1B FTO PIF1 TNS3 CACNA1D CNTRL CRK EVA1C FADS1 MEGF8 LPL KIAA1755 ZFHX3	3.79e-03	1392	219	20	EFO_0005763
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	FAM135B FADS1	4.05e-03	13	219	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	Infantile Severe Myoclonic Epilepsy	SCN1A SCN2A	4.05e-03	13	219	2	C0751122
Disease	Cone-rod synaptic disorder, congenital nonprogressive	GPR179 CACNA1F	4.05e-03	13	219	2	C4041558
Disease	cognitive impairment measurement	PXDNL NAV3 SH3RF3	4.27e-03	44	219	3	EFO_0007998
Disease	mean arterial pressure	SVEP1 NFATC2 PXDNL FTO MOV10 CACNA1D TCF20 IKZF4 ZFHX3 LRBA	4.33e-03	499	219	10	EFO_0006340
Disease	lobe attachment	PLCXD2 NFATC2 FAT4 PRKDC LRBA ADAMTS14	4.62e-03	207	219	6	EFO_0007667
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	FAM135B FADS1	4.71e-03	14	219	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	lysophosphatidylcholine 22:5 measurement	NFATC2 FADS1	4.71e-03	14	219	2	EFO_0021462
Disease	amino acid measurement	RTN4R AXIN2 PASK PTPRB NAV3 UNC5D IPO5 FAT4 RP1L1 PRKDC LRBA TNKS2	4.97e-03	678	219	12	EFO_0005134
Disease	caudate nucleus measurement, functional brain measurement, response to reward	SPACA6 TRHDE FAM135B	5.14e-03	47	219	3	EFO_0007849, EFO_0008387, EFO_0008396
Disease	Autosomal recessive primary microcephaly	WDR62 CEP152	5.40e-03	15	219	2	cv:C3711387
Disease	level of Triacylglycerol (53:3) in blood serum	FADS1 LPL	5.40e-03	15	219	2	OBA_2045165
Disease	Sinus Node Dysfunction (disorder)	PKP2 CACNA1D	5.40e-03	15	219	2	C0428908
Disease	Down syndrome (implicated_via_orthology)	SYNJ1 SYNJ2	5.40e-03	15	219	2	DOID:14250 (implicated_via_orthology)
Disease	MMR-related febrile seizures	SCN1A SCN2A	5.40e-03	15	219	2	EFO_0006519
Disease	cis/trans-18:2 fatty acid measurement, trans fatty acid measurement	FADS1 CDH4	5.40e-03	15	219	2	EFO_0006821, EFO_0006824
Disease	hepatoblastoma (is_marker_for)	AXIN2 ZFHX3	5.40e-03	15	219	2	DOID:687 (is_marker_for)
Disease	high density lipoprotein cholesterol measurement, metabolic syndrome	FADS1 LPL	5.40e-03	15	219	2	EFO_0000195, EFO_0004612
Disease	fat body mass	THSD4 ABCA3 MYCBP2 SCN2A FTO FAM135B	5.79e-03	217	219	6	EFO_0005409
Disease	cognitive inhibition measurement	PXDNL PIF1 TCF20	6.12e-03	50	219	3	EFO_0007969
Disease	response to hydrochlorothiazide, systolic blood pressure change measurement	ZDHHC2 TAF1C	6.14e-03	16	219	2	EFO_0005202, EFO_0006944
Disease	Early infantile epileptic encephalopathy with suppression bursts	SCN1A SCN2A	6.14e-03	16	219	2	C0393706
Disease	diacylglycerol 36:2 measurement	FADS1 LPL	6.14e-03	16	219	2	EFO_0010355
Disease	mean arterial pressure, alcohol drinking	COX5A FTO MOV10 RP1L1	6.19e-03	98	219	4	EFO_0004329, EFO_0006340
Disease	prostate cancer (is_marker_for)	CDKN2A INHA BCL2 ADSL EEF2	6.28e-03	156	219	5	DOID:10283 (is_marker_for)
Disease	vascular endothelial function measurement	ZDHHC2 FRS3 GRID2 CDH4	6.42e-03	99	219	4	EFO_0803369
Disease	severe acute respiratory syndrome, COVID-19	THSD4 KSR1 SYNJ2 FER RASSF3 WDFY4 TG GCNT7 ZFHX3	6.46e-03	447	219	9	EFO_0000694, MONDO_0100096
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	FTO FADS1 LPL	6.46e-03	51	219	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	periodontitis	THSD4 HS6ST2 SCN2A FTO FAM135B ZFHX3	6.58e-03	223	219	6	EFO_0000649
Disease	Vitiligo	HERC2 IKZF4 TG FADS1	6.88e-03	101	219	4	EFO_0004208
Disease	Night blindness, congenital stationary	GPR179 CACNA1F	6.93e-03	17	219	2	C0339535
Disease	Hypermetropia	CHST12 GRIN2C PTPRU ANKFN1	7.36e-03	103	219	4	HP_0000540

Protein segments in the cluster

Peptide	Gene	Start	Entry
HGERRFLGVTQFSPT	TRHDE	256	Q9UKU6
HSRGFIESIRPALEL	NAIP	1036	Q13075
HGRATAGRSRELTPF	AHRR	601	A9YTQ3
DRTTAAHGLELRVPF	ASNS	406	P08243
LSFDSREASFVHGRP	CEP152	1581	O94986
RSGLHKLFPSRDADS	CNTRL	1206	Q7Z7A1
PTSAAVTRAFLERGH	AKR7L	26	Q8NHP1
PTSAAVTRAFLERGH	AKR7A3	26	O95154
VLLPTHRRRGSFSSE	ALKBH5	351	Q6P6C2
VSHRAPTSRFGSAAA	GRM2	826	Q14416
FSINHATGEIRSVRP	FAT4	2716	Q6V0I7
RSAALARHGPAVADL	BTBD17	271	A6NE02
TPARHQSFGAAVLSR	ARHGEF16	101	Q5VV41
AGLTPEERSFHTSRN	CLK3	621	P49761
GAELSFILPRESTHR	ABCA3	791	Q99758
LESARSSPGERASRH	AXIN2	646	Q9Y2T1
SLSASRAPARRLVFH	GIPC2	31	Q8TF65
RLVFRTQLAHGSPTG	GIPC3	36	Q8TF64
SSGARHRLPRELIFV	CEP170B	11	Q9Y4F5
SPVHDAARTGFLDTL	CDKN2D	76	P55273
PLLLRRHFGSSDTFS	DMXL1	1821	Q9Y485
TPLATSFEGRHGSVR	ARRDC3	121	Q96B67
TDFRGRFLSHVVSGP	ADAMTS14	46	Q8WXS8
RFLSHVVSGPAAASA	ADAMTS14	51	Q8WXS8
FAAGHTLTLRVPAAR	ABCA7	2016	Q8IZY2
TAAFKHGRTETIRPA	CPT2	491	P23786
RHGVFLVRDSSTSPG	CRK	31	P46108
HALGVFSSPITARDA	R3HCC1L	681	Q7Z5L2
AGPRTDTLSFVLREH	RASSF3	171	Q86WH2
SNLPHEATRDTIFRG	CYP2E1	366	P05181
LRGASIFSLTAHDPD	PCDHGA8	466	Q9Y5G5
IFPSRRNEVRTHVGS	GRSF1	321	Q12849
QSFTLRGDHRSPASA	NET1	121	Q7Z628
RHRAATSEEPTGFSV	ARHGEF17	741	Q96PE2
AHSRAGIPEAFTTLG	ANKAR	1241	Q7Z5J8
VSLAAEDPIRAHSFR	CACNA1F	886	O60840
NTHRRGSGALIFTIP	CACNA1F	1716	O60840
FRVHIPESSGRIVSL	NFATC2	546	Q13469
FIFGRTVPASVSHLR	PTPRB	1166	P23467
SHRTFGRSLSSDPRA	PARP8	336	Q8N3A8
ARTRLFLASLPGSTH	PASK	941	Q96RG2
AAAPGALVRDVHSLS	LFNG	61	Q8NES3
ASELPSGRLFHAAAV	LZTR1	381	Q8N653
ALARLTGPAHRAALA	NLRC3	591	Q7RTR2
EVHVRRSHSGTRPFA	GFI1	271	Q99684
FRLHSATLAPIGSRG	NUDT22	61	Q9BRQ3
FPEALARQHSRDSGS	GPR179	726	Q6PRD1
PALGFRSASAHNLTV	GPR179	811	Q6PRD1
LRSITHSFVGRPSEG	HERC2	2171	O95714
ASRLDFSPDVRSHLA	KIAA1755	796	Q5JYT7
AGSQPRFSSTHRVAE	FTO	311	Q9C0B1
VFPLRESHTLTVREG	HMCN2	2171	Q8NDA2
FDRSHRGRISNTELP	KATNIP	906	O60303
PFTRGRSHSITIDFT	KATNIP	1051	O60303
TGRSFAVHTRRENPA	ASPDH	236	A6ND91
ADHPGLTFSLRLIRS	FREM2	2771	Q5SZK8
LHPRTTGFTFVVDRL	LCLAT1	231	Q6UWP7
AVLLPASRFLSVHTR	DCAF4L1	156	Q3SXM0
HLFIQRSTAGTPRSG	GRID2	116	O43424
IFSTAHRGSALPLAI	PLXNA1	1701	Q9UIW2
VFSTAHRGSALPLAI	PLXNA3	1676	P51805
ASGRLTPRALHSFIT	KSR1	256	Q8IVT5
VHNFPGTSRRLSALG	KPTN	206	Q9Y664
VDVLHTFTRGSPGRS	LPL	206	P06858
VPQHVLSRRGAISFS	PDE7A	16	Q13946
ATSLEERPRAISHSG	NAV3	1521	Q8IVL0
ERPRAISHSGSFRDS	NAV3	1526	Q8IVL0
ITFSGRPSRVHASEV	FBXO39	61	Q8N4B4
AHITLRTGAFTDAGP	MEX3D	336	Q86XN8
HNVSARDPAFSARIG	MEGF8	216	Q7Z7M0
SSRLFFVGSREGHLP	SLC7A5	346	Q01650
VDFAPFLSRTLLGSH	LRBA	1816	P50851
HRPVTATSAGRARVL	LINGO3	446	P0C6S8
RQRSALPATGHFTAR	EXPH5	326	Q8NEV8
TFKSHRVPASGDLRD	KREMEN1	416	Q96MU8
TGSFLHTLEGPRFRA	PGGHG	86	Q32M88
FSGHTPDRVRNLFSL	PCDHGC4	281	Q9Y5F7
FARLSEHATAPTRGS	DUT	116	P33316
HPSIRTLSARATAAF	IPO5	186	O00410
FATALDTTRHELPVR	HAUS8	236	Q9BT25
RSRLGSHPLLFSGEV	DXO	221	O77932
STILRLPAAAFHGVF	PNPLA7	241	Q6ZV29
SHRRFLATFPLAAVS	PTPRU	241	Q92729
HSAPFVARALRIRSS	PPP1R37	206	O75864
HFLLRPTSIRVREGS	OBSCN	111	Q5VST9
RFHRLILTPATFSGL	GLYATL3	271	Q5SZD4
HTVPALSTARFSDGR	PXDNL	816	A1KZ92
RSLDSESISPGDFHR	ARHGAP29	551	Q52LW3
TFGGHDPRTAVQLRS	PIKFYVE	116	Q9Y2I7
RAHPERAALLFVSSV	EVA1C	316	P58658
ATLTRPVHDAAREGF	CDKN2A	76	P42771
RRTNSSSPLGELFDH	CEPT1	141	Q9Y6K0
RRILTTSSAHPGLEF	FASTKD5	66	Q7L8L6
FLRHSRTPSSDGTVE	IGSF21	286	Q96ID5
GEIHAFLSSPSGRRT	CCNF	556	P41002
ISRGLHFITRPLSAE	GCNT7	91	Q6ZNI0
FESIRHSIAGIIRSP	FER	421	P16591
TRAAIRSHGSFPVPL	FRS3	376	O43559
VSRFLARAGLPSTHL	B3GAT2	126	Q9NPZ5
LRFISSHQTGIPARG	CNTF	176	P26441
RPKRHFSSAGTIESV	CRACD	126	Q6ZU35
EGTRFLHGARLSPLS	IDI2-AS1	71	Q9NZ38
RFHRVGPIEATSFIL	EBI3	176	Q14213
LAHISGASSFEPRSL	DDX50	566	Q9BQ39
RIISGDPSGHFSVRT	CDH4	431	P55283
SEFTRRHPGGSRVIS	FADS1	46	O60427
SPSLLFIFVRHGVES	EIF4G1	1271	Q04637
TFRAPRAHTVVGDLL	FCRL3	386	Q96P31
SRHEAFPLRVIDSGT	MAN2A2	746	P49641
SARPEATPFLVAHTR	INHA	206	P05111
FILLTRHRTAFPASG	KCNMB3	16	Q9NPA1
HSRVEAELAASRPGS	HS6ST2	31	Q96MM7
ALVPRAFHASAVGLR	COQ9	31	O75208
PGHVDFSSEVTAALR	EEF2	106	P13639
VSSRIPHRLSASIAG	FAM135B	36	Q49AJ0
ESTIIDSPRFSHRGI	HEXB	191	P07686
DSPRFSHRGILIDTS	HEXB	196	P07686
RIPAHRFVLAVGSAV	BTBD2	131	Q9BX70
VAATTRADPRGLLHS	COX5A	11	P20674
ASQGPASHSRFSRDR	SLC15A3	566	Q8IY34
HGEAAVIRAPRIASF	SDK2	126	Q58EX2
ARIRPAQLTHRGTFS	SPACA6	211	W5XKT8
RHRVSLFGTDAPAVV	RYR1	3051	P21817
AALAAEDPIRSHSFR	CACNA1D	901	Q01668
EDPIRSHSFRNTILG	CACNA1D	906	Q01668
SSLAFVGAEHLRPLR	IKZF4	371	Q9H2S9
VSRSPLEHGTVLFAR	NGB	16	Q9NPG2
LSLFLRGSAPTAARH	NOA1	11	Q8NC60
FPRAASTTRTQHRGE	LRRN4	446	Q8WUT4
AVPTHSGSELRSFRN	NR2E1	296	Q9Y466
PRGASIFSVRAHDLD	PCDHGA1	466	Q9Y5H4
SAFPHLRVLEATARA	PAOX	36	Q6QHF9
AFSSRHFREPGLSIL	ITPRIPL2	86	Q3MIP1
VTLASKFESGSHPRR	GUCY1A2	641	P33402
HARAAPSRGTARLDS	NUTM2A	631	Q8IVF1
HARAAPSRGTARLDS	NUTM2B	631	A6NNL0
SSPRRSLGLALTHSF	NAV1	1381	Q8NEY1
PVRFTISSRTDAGVH	PUSL1	56	Q8N0Z8
LAPLSSSRSRFHAFI	RUSC1	586	Q9BVN2
SSVPERAFRGLHSLD	RTN4R	191	Q9BZR6
AEAGRSTLRLPAHDT	PIF1	81	Q9H611
FTPLARHRTLTAEEA	GTF2F1	146	P35269
LATHRAFTSTPALLG	RGL2	121	O15211
HSAAFRRAPAAAAET	RNPEPL1	86	Q9HAU8
SANPGRFHTSERIRG	TRMT1	416	Q9NXH9
GASLALRVSFVDVHP	TDRD6	11	O60522
HIAIRGPVSRTFVLA	SYNM	1416	O15061
RAGVISAPQSHARAS	SYNJ1	1201	O43426
LEAVGEFRHRSPSRS	SYNJ2	1081	O15056
ESRPSVLRGDHLFAL	MOV10	386	Q9HCE1
RSRASIAVAPFDHDS	PLEKHG4	1076	Q58EX7
SSRAVARIFHGIGSP	RECQL4	1156	O94761
ADFTAHPRVLTVGDR	TAF1C	391	Q15572
PHSTVRGSGTFILVR	NFAM1	136	Q8NET5
RDFSAPLTISRVHAG	PDLIM4	21	P50479
AKERASLPTLGFTHF	ADSL	146	P30566
AGHLTRAVEPLRTFS	NAGPA	91	Q9UK23
PESAHRLAVRFTSLG	DHODH	51	Q02127
ELHRQRSPGVSFGLS	SLC38A6	36	Q8IZM9
SHDAVLRFNSAPTRG	ST6GAL2	316	Q96JF0
FVAKDSAGLRIRSHP	MYCBP2	2471	O75592
FPELTKRTDGLHFRT	SI	1421	P14410
PGSFIVRDSHSFRGA	TNS3	1191	Q68CZ2
EHPAERVRSAFAAPS	TBC1D3L	496	B9A6J9
AILTHGIFSGPAISR	PRPS1L1	246	P21108
ARRALHEDLPSGSFI	SVEP1	256	Q4LDE5
VGTGETPLHLAARFS	NOTCH4	1631	Q99466
HTVTTRFILLGFPTR	OR6Y1	11	Q8NGX8
RSHFTRPAGVSSAVI	URB1	1281	O60287
RSVAEHPLSRAEAAG	URB1	2106	O60287
LPSHRTAFSLGRGSI	POM121L2	946	Q96KW2
AVIPEFSRHRSSGRI	SPEM1	246	Q8N4L4
SLFHARPGLSTLSAE	RRP12	351	Q5JTH9
ASEHSREPSAAGRLS	SCN1A	466	P35498
TPAHEVGRRTSVLFS	BRPF1	881	P55201
SSQLHLTPFTARGRF	BCL2	116	P10415
VRVTSTGRPGHASRF	ACY1	196	Q03154
TGARESPHFVSLESR	ANKFN1	196	Q8N957
HTSLPASAREAFRAG	CHST12	281	Q9NRB3
PLIRHRALAAETFSA	CHRD	271	Q9H2X0
RPALETEGLRFLHTT	SELENOS	11	Q9BQE4
EHPAERVRSAFAAPS	TBC1D3B	496	A6NDS4
EHPAERVRSAFAAPS	TBC1D3H	496	P0C7X1
APRGLSSEARASLHQ	RINL	516	Q6ZS11
LRASLVHVGSRPYTE	VWA1	71	Q6PCB0
ITGSRHRTRLFFPSS	USP19	71	O94966
ASGPALSRHLLTSFV	PIK3R5	366	Q8WYR1
FGVRSVTTPRGLHSL	RP1L1	76	Q8IWN7
VLSRERGLSFHQFPT	THAP9	16	Q9H5L6
EHPAERVRSAFAAPS	TBC1D3F	496	A6NER0
PLRIRFATHGAALTV	PSPC1	146	Q8WXF1
VSTRAALVPAAAGFH	SLC26A1	596	Q9H2B4
SVSPSASFRGAEKHR	TLE4	206	Q04727
SRGSFHVSQAILTPR	PLCXD2	256	Q0VAA5
QIRLHATGFRDPSTE	TAS2R9	211	Q9NYW1
SSDPRAAARIGDLAH	SH3RF3	411	Q8TEJ3
APSFEGGSRRLSHSL	PLCH2	1266	O75038
AILTHGIFSGPAISR	PRPS2	246	P11908
LITNTERRHPGFEAT	ST14	316	Q9Y5Y6
AERSSLIPISGHRAS	SAP130	451	Q9H0E3
RFHATRGPDVSLSAD	NEURL1B	281	A8MQ27
RFSSPHQSLLSIRGS	SCN2A	551	Q99250
SVFGPAARRILAVAH	TMEM52B	106	Q4KMG9
ERVRVGAFQFSSTPH	VWA2	86	Q5GFL6
TSGSPLHSRLIRIFE	WDFY4	896	Q6ZS81
GVRVFHSSPAASSLD	WDFY4	1356	Q6ZS81
FPSSFRIHERTHTGE	ZNF627	346	Q7L945
FARSLVPSSERLHLS	SPATA7	146	Q9P0W8
ALSGHPLRFSEREGS	STAB1	1666	Q9NY15
EHPAERVRSAFAAPS	TBC1D3E	496	A0A087X179
VHGSSRLEEFSPRQA	TCF20	21	Q9UGU0
LPTRTELRTTGVFGH	UNC5D	536	Q6UXZ4
SRDTAGRKSTPLHFA	TNKS2	51	Q9H2K2
AVPSAGLRLFALHAS	PRKDC	266	P78527
FRVSHSPLLEAEAGR	nan	141	Q8IYB0
PVEESALRLHGSAFR	WDR62	1326	O43379
FRASRIILNSHSPAG	USP24	1601	Q9UPU5
AILTHGIFSGPAISR	PRPS1	246	P60891
EHPAERVRSAFAAPS	TBC1D3D	496	A0A087WVF3
STLEAFRSPVFRHGT	ZDHHC2	241	Q9UIJ5
RSPFGHREAAADVSV	VSIG10L	381	Q86VR7
GSAVKRFSISFARHP	PPIP5K2	1101	O43314
PARAFADHVVSAVRT	THSD4	96	Q6ZMP0
VLGSHERGPSLSFRS	RIPOR1	26	Q6ZS17
EHPAERVRSAFAAPS	TBC1D3G	496	Q6DHY5
EHPAERVRSAFAAPS	TBC1D3	496	Q8IZP1
RDHEAVPLSVFRAGT	TPGS1	171	Q6ZTW0
TIRFLQGDHFGTSPR	TG	1421	P01266
RSRPEAHTLLTAGSD	WDR87	251	Q6ZQQ6
HSTRTLREAGPSVAV	PKP2	296	Q99959
PSVAVDSSGRRAHLT	PKP2	306	Q99959
PSSFQRAGSVRDRVH	SMTN	321	P53814
EHPAERVRSAFAAPS	TBC1D3K	496	A0A087X1G2
EHPAERVRSAFAAPS	TBC1D3I	496	A0A087WXS9
EHPAERVRSAFAAPS	TBC1D3C	496	Q6IPX1
RHPLGSQRVSLSFSV	SIGLEC16	411	A6NMB1
TALFSEARSPGREKH	VWA5B1	971	Q5TIE3
LAGLSPVLHSFRVFD	ZFHX3	221	Q15911
RREGVPAHVNLSASS	UNC79	211	Q9P2D8
NEPRSSSRIGLRVHF	MYPN	586	Q86TC9
RPRHASLPSSVAEAF	GRIN2C	1076	Q14957
SFVAVTTRAPGHRAF	GRIN2D	186	O15399